BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7348979)

  • 1. Histological characteristics and biological behavior of oligodendrogliomas.
    Smith MT; Ludwig CL; Armbrustmacher VW; Henry JM; Earle KM
    Trans Am Neurol Assoc; 1980; 105():35-7. PubMed ID: 7348979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between the morphological and clinical characteristics in astrocytomas and supratentorial oligodendrogliomas].
    Alwasiak J
    Neuropatol Pol; 1981; 19(4):615-30. PubMed ID: 7347383
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral oligodendrogliomas. Clinical manifestations, surgical treatment and histological findings in seventy cases.
    Wislawski J
    Pol Med J; 1970; 9(1):163-72. PubMed ID: 4985390
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain scanning in oligodendrogliomas: a detailed neuropathology-scan correlation of 34 histologically verified cases.
    Schall GL; Heffner RR; Handmaker H
    Radiology; 1975 Aug; 116(02):367-72. PubMed ID: 1153739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pathologic correlations between "pure" and "transitional" oligodendrogliomas].
    Hlavka V; Jelicić I; Miklić P
    Acta Med Iugosl; 1988; 42(1):31-43. PubMed ID: 3364211
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various features of the morphology, clinical picture and treatment of oligodendrogliomas of the cerebral hemispheres].
    Romodanov AP; Malikov AI
    Zh Vopr Neirokhir Im N N Burdenko; 1980; (5):23-7. PubMed ID: 7435065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oligodendrogliomas: anatomo-clinical study (author's transl)].
    Andrioli GC; Trincia G; Scanarini M; Rigobello L
    Pathologica; 1978; 70(999-1000):53-61. PubMed ID: 652396
    [No Abstract]   [Full Text] [Related]  

  • 8. [An operative series of 27 cases of oligodendrogliomas].
    Lloret J; Argüello C; Gutiérrez M; Manrique M; Blazquez MG
    Rev Esp Otoneurooftalmol Neurocir; 1979 Mar; 37(206):4-5. PubMed ID: 461923
    [No Abstract]   [Full Text] [Related]  

  • 9. Imaging molecular signatures in oligodendroglioma.
    Cairncross JG
    Clin Cancer Res; 2004 Nov; 10(21):7109-11. PubMed ID: 15534080
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological study of oligodendrogliomas in Aragon and La Rioja].
    Pascual-Piazuelo M; Bestué M; Serrano-Ponz M
    Rev Neurol; 2002 May 16-31; 34(10):997-8. PubMed ID: 12134334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical characteristics of oligodendrogliomas of the brain in the age aspect].
    Malikov AI
    Vrach Delo; 1980 May; (5):77-9. PubMed ID: 7395172
    [No Abstract]   [Full Text] [Related]  

  • 12. [The oligodendroglioma: the value of histologic and genetic diagnosis in predicting sensitivity to chemotherapy].
    Kros JM
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1379-85. PubMed ID: 15997690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic oligodendrogliomas: a review of the literature and case report.
    Zustovich F; Della Puppa A; Scienza R; Anselmi P; Furlan C; Cartei G
    Acta Neurochir (Wien); 2008 Jul; 150(7):699-702; discussion 702-3. PubMed ID: 18548193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendroglioma with a twenty-two year history. Clinicopathological case report.
    Aebi M; Kraus-Ruppert R
    J Neurol; 1978 Oct; 219(2):139-44. PubMed ID: 81292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrogliomas.
    Reiche W; Grunwald I; Hermann K; Deinzer M; Reith W
    Acta Radiol; 2002 Sep; 43(5):474-82. PubMed ID: 12423457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendroglioma with neurocytic differentiation and characteristic loss of heterozygosity on chromosomes 1p and 19q.
    Vajtai I; Arnold M; Vassella E
    Acta Neuropathol; 2005 Nov; 110(5):520-2. PubMed ID: 16222523
    [No Abstract]   [Full Text] [Related]  

  • 18. [A rare case of dissemination of anaplastic oligodendroma outside the central nervous system].
    Rolski J; Rzepecki W; Kałuza J; Zemełka T; Zuchowska-Vogelgesang B
    Neurol Neurochir Pol; 1993; 27(1):93-7. PubMed ID: 8502365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignancy criteria in oligodendrogliomas].
    Mennel HD
    Strahlenther Onkol; 2000 Nov; 176(11):539. PubMed ID: 11143532
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas.
    Watson MA; Perry A; Budhraja V; Hicks C; Shannon WD; Rich KM
    Cancer Res; 2001 Mar; 61(5):1825-9. PubMed ID: 11280731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.